• 作者：Sté ; phane Bart¹ ; ^{stephane.bart2@wanadoo.fr} ; Pierre Mozer¹ ; Alexia Even-Schneider² ; Pierre Denys² ; Franç ; ois Richard¹ ; Emmanuel Chartier-Kastler¹ ; ²
• 关键词：Hypertrophie bé ; nigne de prostate ; prothè ; se endo-uré ; thrale ; troubles de la miction
• 刊名：Progr¨¨s en Urologie - FMC
• 出版年：2008
• 出版时间：September 2008
• 年：2008
• 卷：18
• 期：2
• 页码：F25-F28
• 全文大小：301 K

Temporary transprostatic urethral stenting, such as Urospiral? may be useful in the treatment of symptomatic benign prostatic hyperplasia (BPH). It should be particularly recommended in BPH patients with a high surgical risk, avoiding the use of indwelling catheter. It can also be used as a therapeutic test in patients with bladder outlet obstruction or irritation, suspected to be due to neurological disorders.

Urospiral?is a temporary, non-expanding transprostatic stent with a fixed external calibre of 21 F. Various lengths are available to adapt the stent to the length of the bladder neck and veru montanum. The median part of the stent maintains urinary continence. Stenting and stent removal are performed by urethrocystoscopy, after endourethral Xylocaine gel local anaesthesia.